-
Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025
10 Apr 2025 20:24 GMT
Gilead Sciences, Inc. (Nasdaq: GILD) announced today … there for one year.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company … , California.
For more information on Gilead Sciences, please visit the company’s …
-
Alert-based patient-reported outcome monitoring improves breast cancer symptom control
15 Apr 2025 15:09 GMT
… Pharmaceuticals, Daiichi Sankyo, Genentech, Gilead Sciences and Pfizer.
Sources/ … consulting roles with AstraZeneca, Gilead Sciences, Pfizer and Roche, as … Horizon Health, Gemeinsamer Bundesausschuss, Gilead Sciences and Stiftung Charité. Please …
-
The fallout from UnitedHealth’s CEO slaying
15 Apr 2025 14:07 GMT
… protect CEO Albert Bourla, while Gilead Sciences reported more than $285,000 …
-
Amgen bumps up pay for longtime CEO Robert Bradway 8% to $24.4M
15 Apr 2025 00:13 GMT
… Joaquin Duato ($24.3 million), Gilead Sciences' Daniel O’Day ($23 …
-
The Elizabeth Taylor AIDS Foundation Issues Emergency Grant Cycle to Address Forthcoming Gap Funding
14 Apr 2025 19:07 GMT
… communities, ETAF in partnership with Gilead Sciences, Inc. works to modernize the …
-
Gilead reprimanded after PMCPA finds conference Wi-Fi sponsorship broke advertising rules
14 Apr 2025 18:23 GMT
Gilead Sciences’ sponsorship of a conference Wi- …
-
West Virginia Rep. Carol Miller Bought Up to $135K Worth of Aflac Stock
14 Apr 2025 15:55 GMT
… ,000
P
2025-03-10
Gilead Sciences
GILD
STOCK
$1,001 - …
-
Is Iovance Biotherapeutics a Millionaire-Maker?
14 Apr 2025 14:11 GMT
… CAR-T therapies such as Gilead Sciences' Yescarta and Tecartus, which … has positions in and recommends Gilead Sciences, Iovance Biotherapeutics, and Merck. The …
-
IDEAYA Biosciences begins phase 1/2 clinical trial to evaluate IDE397 and Trodelvy combination in MTAP─deletion urothelial cancer
14 Apr 2025 12:08 GMT
… and Gilead are trademarks of Gilead Sciences, Inc., or its related companies …
-
Approval moves Columvi earlier in DLBCL treatment pathway
14 Apr 2025 12:25 GMT
… -T therapies for NHL like Gilead Sciences' Yescarta (axicabtagene ciloleucel), Novartis …